Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Muscle-invasive Urothelial Carcinoma of the Bladder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)WithdrawnNCT07342517
What this trial is testing

NDV-01 as an Intravesical Administration to Patients With BCG-Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC), Refractory to First-line Therapy

Who this might be right for
Bladder (Urothelial, Transitional Cell) CancerBladder (Urothelial, Transitional Cell) Cancer Superficial (Non-Invasive)Urothelial Carcinoma Bladder+2 more
Relmada Therapeutics, Inc.
Testing effectiveness (Phase 2)WithdrawnNCT03150836
What this trial is testing

Radiation Therapy and Durvalumab, With or Without Tremelimumab, in Patients With Bladder Cancer

Who this might be right for
Bladder Cancer
Terence Friedlander, MD
Testing effectiveness (Phase 2)UnknownNCT04543110
What this trial is testing

Radiation and Durvalumab Immunotherapy As Neoadjuvant Treatment for MIBC

Who this might be right for
Bladder Cancer
Ottawa Hospital Research Institute 16
Early research (Phase 1)Study completedNCT01162785
What this trial is testing

1B Intravesical Administration of SCH 721015 (Ad-IFNa) in Admixture With SCH 209702 (Syn3) for The Treatment of BCG Refractory Superficial Bladder Cancer

Who this might be right for
Bladder Cancer
M.D. Anderson Cancer Center 7
Large-scale testing (Phase 3)Ended earlyNCT01310803
What this trial is testing

Multi-center Study to Evaluate the Efficacy and Safety of Maintenance Therapy With Valrubicin Versus no Maintenance, in Subjects Treated With Valrubicin Induction for Carcinoma in Situ (CIS) of the Bladder

Who this might be right for
Carcinoma in SituTransitional Cell CarcinomaNon-muscle Invasive Bladder Cancer
Endo USA Inc., a Keenova Therapeutics Company 1
Not applicableLooking for participantsNCT07756437
What this trial is testing

Validation of a Circulating Tumor DNA Blood Test in Muscle-Invasive Bladder and Upper Tract Urothelial Cancer

Who this might be right for
Muscle-Invasive Bladder Cancer (MIBC)Upper Tract Urothelial CarcinomaUrothelial Carcinoma (UC)
AZ Sint-Lucas Gent 70
Not applicableUnknownNCT05276167
What this trial is testing

Hyperthermic Intravesical Perfusion for Muscle-invasive Bladder Urothelial Carcinoma

Who this might be right for
High-Risk, Non-Muscle Invasive Bladder Urothelial CarcinomaPerfusion; ComplicationsIntraoperative Complications
Henan Cancer Hospital 40
Not applicableLooking for participantsNCT06167356
What this trial is testing

Study on the Occurrence of Possible Relapses and on the Quality of Life in Patients Who Underwent TURBK.

Who this might be right for
Non Muscle Invasive Bladder CancerNon-Muscle Invasive Bladder NeoplasmsNon-Muscle Invasive Bladder Urothelial Carcinoma+8 more
IRCCS San Raffaele 20,000
Large-scale testing (Phase 3)Ended earlyNCT00384891
What this trial is testing

Hyperthermia Treatment in Conjunction With Mitomycin C Versus Bacillus Calmette-Guérin Immunotherapy (BCG) for Superficial Bladder Cancer

Who this might be right for
Urinary Bladder DiseasesUrinary Bladder NeoplasmsUrinary Bladder Cancer+5 more
Medical Enterprises Europe B.V. 190
Testing effectiveness (Phase 2)Active Not RecruitingNCT05535218
What this trial is testing

Pembrolizumab-Sacituzumab Govitecan Combination to Treat High-risk, Localized Bladder Cancer

Who this might be right for
Muscle-invasive Urothelial Carcinoma of the Bladder
Claudia Guerrieri 48
Early research (Phase 1)WithdrawnNCT05259397
What this trial is testing

PF-07225570 Alone or in Combination With an Anti-PD-1 Antibody in Recurrent Non-muscle Invasive Bladder Cancer (NMIBC)

Who this might be right for
Bladder Cancer
Pfizer
Not applicableActive Not RecruitingNCT04167631
What this trial is testing

Can VI-RADS/ADC Accurately Stage Bladder Cancer??

Who this might be right for
MRI Contrast Media Adverse ReactionBladder CancerBladder Disease+4 more
Mansoura University 150
Large-scale testing (Phase 3)Looking for participantsNCT06493552
What this trial is testing

Modular Trial of sEphB4-HSA in EphrinB2-High Solid Tumors

Who this might be right for
Muscle-Invasive Bladder CarcinomaMetastatic Urothelial Carcinoma
Vasgene Therapeutics, Inc 700
Large-scale testing (Phase 3)Active Not RecruitingNCT05243550
What this trial is testing

Single-Arm Study of UGN-102 for Treatment of Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer

Who this might be right for
Bladder CancerUrothelial CarcinomaUrothelial Carcinoma Bladder
UroGen Pharma Ltd. 240
Testing effectiveness (Phase 2)Active Not RecruitingNCT05406713
What this trial is testing

Pembrolizumab in Muscle-invasive Bladder Cancer

Who this might be right for
Muscle Invasive Bladder CarcinomaLocalized CancerUrothelial Carcinoma
Matthew Galsky 46
Large-scale testing (Phase 3)Ended earlyNCT02982395
What this trial is testing

Study to Evaluate the Efficacy and Safety Of Intravesical Nanoxel®M In BCG Refractory NMIBC

Who this might be right for
Non Muscle Invasive Bladder Cancer
Samyang Biopharmaceuticals Corporation 36
Testing effectiveness (Phase 2)UnknownNCT03061630
What this trial is testing

A Prospective Study of Neoadjuvant Chemotherapy With Gemcitabine/Platinum in Muscle-Invasive or Locally-Advanced Urothelial Carcinoma of Bladder

Who this might be right for
Urinary Bladder
Samsung Medical Center 49
Early research (Phase 1)Ended earlyNCT05014139
What this trial is testing

Intravesical Enfortumab Vedotin For Treatment of Patients With Non-muscle Invasive Bladder Cancer (NMIBC)

Who this might be right for
Urinary Bladder NeoplasmsCarcinoma in SituCarcinoma Transitional Cell+2 more
Astellas Pharma Global Development, Inc. 37
Testing effectiveness (Phase 2)Study completedNCT04383743
What this trial is testing

Pembrolizumab and Combination Chemotherapy Before Surgery for the Treatment of Muscle-Invasive Bladder Cancer

Who this might be right for
Stage II Bladder Cancer AJCC v8Stage IIIA Bladder Cancer AJCC v8Muscle Invasive Bladder Carcinoma
University of Washington 17
Testing effectiveness (Phase 2)UnknownNCT05418309
What this trial is testing

Tilelizumab Combined With Nab-Paclitaxel for High-Risk Non-Muscle-Invasive Urothelial Bladder Carcinoma Which is Not Completely Resectable: a Multi-center Study

Who this might be right for
High-Risk Non-Muscle Invasive Bladder Urothelial Carcinoma
Tianjin Medical University Second Hospital 63
Next Page